Fidelity SPDR Advertisement
Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 300
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
EU Gives Russia A Week to Avoid More Sanctions
European Union leaders agreed late Saturday to draw up options within a week for possible new sanctions against Russia, with action to follow quickly unless Moscow takes clear steps to scale back its intervention in Ukraine.
Apple's New Whiz Kids
J.P. Morgan Working With Law Enforcement on Cyber Attack -- Update
U.S. Hot Stocks: Hot Stocks to Watch
Ex-LPL Broker Ordered to Pay Nearly $2 Million
J.P. Morgan Working With Law Enforcement on Cyber Attack -- 3rd Update
U.S. Hot Stocks: Hot Stocks to Watch
Amazon, Twitter Gains Lead Techs Higher
Amazon Among Gainers In Mild Tech Trading
ADR Shares End Higher; Telefonica, Ryanair Shares Active
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 643787 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist